FUJIFILM Diosynth Biotechnologies

NEWS
With this capital investment, the site will be able to double its current drug substance manufacturing capacity and enhance its existing assembly operations. Production lines for bulk drug substance will be expanded, and development will begin on a new fill/finish production line.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 30, 2020.
Companies strengthen their leadership teams and executive boards with this week’s Movers & Shakers.
The new facility, which could be open by the end of 2021, will be supported by Harvard University, Massachusetts Institute of Technology, GE Healthcare Life Sciences, Alexandria Real Estate Equities and FUJIFILM Diosynth Biotechnologies.
Despite the changing landscape in biopharma, many companies are still recruiting. If you’re looking to make a career change, here are 12 biopharma companies hiring on BioSpace now.
JOBS
IN THE PRESS